Feeds › Insider trades
Insider trades
Open-market buys and sells by officers, directors and 10% owners, from SEC Form 4. Usually filed within two business days.
About this data
- What it is
- When a company's officers, directors or owners of more than 10% buy or sell its stock, they must report the trade to the SEC on Form 4. This feed shows purchases and sales on the open market; stock grants, option exercises and shares withheld for tax are left out.
- Who files it
- The insider, usually through the company, within two business days of the trade.
- How current
- We collect new filings throughout the day on SEC business days.
- Worth knowing
- Sales are often routine: insiders sell to diversify, to pay taxes, or under a 10b5-1 plan set up months in advance. A purchase with their own money is less common, which is why many investors pay closer attention to it.
All of this comes from public filings.
Source and freshness · Information, not investment advice (disclaimer).
Open-market trades per day, last 30 days
Purchases Sales
By trade date. Insiders have two business days to file, so the most recent days fill in later.
Latest open-market insider trades
Showing: ticker BEAM
| Traded | Insider | Company | Type | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| Oct 16, 2026 | John M. Evans CEO, Director | BEAM Beam Therapeutics Inc. | Sale | 25,000 | $23.98 | $599.6K Sale | Form 4 ↗ |
| Oct 15, 2026 | John M. Evans CEO, Director | BEAM Beam Therapeutics Inc. | Sale | 25,000 | $23.57 | $589.1K Sale | Form 4 ↗ |
| Jul 27, 2026 | Amy Simon Chief Medical Officer | BEAM Beam Therapeutics Inc. | Sale | 16,667 | $25.74 | $429.0K Sale | Form 4 ↗ |
| Jun 30, 2026 | Amy Simon Chief Medical Officer | BEAM Beam Therapeutics Inc. | Sale | 373 | $34.73 | $13.0K Sale | Form 4 ↗ |
| Jun 30, 2026 | John M. Evans CEO, Director | BEAM Beam Therapeutics Inc. | Sale | 1,900 | $34.84 | $66.2K Sale | Form 4 ↗ |
| Jun 30, 2026 | John M. Evans CEO, Director | BEAM Beam Therapeutics Inc. | Sale | 23,100 | $34.26 | $791.4K Sale | Form 4 ↗ |
| Jun 29, 2026 | John M. Evans CEO, Director | BEAM Beam Therapeutics Inc. | Sale | 11,579 | $35.91 | $415.8K Sale | Form 4 ↗ |
| Jun 29, 2026 | John M. Evans CEO, Director | BEAM Beam Therapeutics Inc. | Sale | 13,421 | $35.13 | $471.5K Sale | Form 4 ↗ |
| Jun 26, 2026 | FMR LLC 10% owner | BEAM Beam Therapeutics Inc. | Sale | 251,488 | $35.26 | $8.9M Sale | Form 4 ↗ |
| Jun 25, 2026 | FMR LLC 10% owner | BEAM Beam Therapeutics Inc. | Sale | 33,372 | $35.12 | $1.2M Sale | Form 4 ↗ |
| Apr 1, 2026 | John M. Evans CEO, Director | BEAM Beam Therapeutics Inc. | Sale | 30,078 | $24.58 | $739.3K Sale | Form 4 ↗ |
| Apr 1, 2026 | Amy Simon Chief Medical Officer | BEAM Beam Therapeutics Inc. | Sale | 6,700 | $24.58 | $164.7K Sale | Form 4 ↗ |
| Apr 1, 2026 | Bethany J. Cavanagh SVP, Finance and Treasurer | BEAM Beam Therapeutics Inc. | Sale | 3,242 | $24.58 | $79.7K Sale | Form 4 ↗ |
| Apr 1, 2026 | Christine Bellon Chief Legal Officer | BEAM Beam Therapeutics Inc. | Sale | 5,956 | $24.58 | $146.4K Sale | Form 4 ↗ |
| Apr 1, 2026 | Giuseppe Ciaramella President | BEAM Beam Therapeutics Inc. | Sale | 11,810 | $24.58 | $290.3K Sale | Form 4 ↗ |
| Mar 31, 2026 | John M. Evans CEO, Director | BEAM Beam Therapeutics Inc. | Sale | 25,000 | $22.76 | $569.0K Sale | Form 4 ↗ |
| Mar 30, 2026 | John M. Evans CEO, Director | BEAM Beam Therapeutics Inc. | Sale | 25,000 | $22.37 | $559.3K Sale | Form 4 ↗ |
| Feb 24, 2026 | Giuseppe Ciaramella President | BEAM Beam Therapeutics Inc. | Sale | 35,000 | $32.00 | $1.1M Sale | Form 4 ↗ |
| Jan 30, 2026 | John M. Evans CEO, Director | BEAM Beam Therapeutics Inc. | Sale | 2,906 | $29.00 | $84.3K Sale | Form 4 ↗ |
| Jan 30, 2026 | John M. Evans CEO, Director | BEAM Beam Therapeutics Inc. | Sale | 22,094 | $28.27 | $624.6K Sale | Form 4 ↗ |
| Jan 29, 2026 | John M. Evans CEO, Director | BEAM Beam Therapeutics Inc. | Sale | 8,667 | $29.74 | $257.8K Sale | Form 4 ↗ |
| Jan 29, 2026 | John M. Evans CEO, Director | BEAM Beam Therapeutics Inc. | Sale | 16,333 | $29.19 | $476.8K Sale | Form 4 ↗ |
| Jan 22, 2026 | Bethany J. Cavanagh SVP, Finance and Treasurer | BEAM Beam Therapeutics Inc. | Sale | 6,198 | $35.00 | $216.9K Sale | Form 4 ↗ |
| Jan 22, 2026 | Christine Bellon Chief Legal Officer | BEAM Beam Therapeutics Inc. | Sale | 1,371 | $34.00 | $46.6K Sale | Form 4 ↗ |
| Jan 20, 2026 | Bethany J. Cavanagh SVP, Finance and Treasurer | BEAM Beam Therapeutics Inc. | Sale | 3,034 | $30.12 | $91.4K Sale | Form 4 ↗ |
| Jan 15, 2026 | Christine Bellon Chief Legal Officer | BEAM Beam Therapeutics Inc. | Sale | 559 | $35.40 | $19.8K Sale | Form 4 ↗ |
| Jan 15, 2026 | Christine Bellon Chief Legal Officer | BEAM Beam Therapeutics Inc. | Sale | 15,959 | $34.72 | $554.1K Sale | Form 4 ↗ |
| Jan 15, 2026 | Christine Bellon Chief Legal Officer | BEAM Beam Therapeutics Inc. | Sale | 2,111 | $33.62 | $71.0K Sale | Form 4 ↗ |
| Dec 31, 2025 | Sravan Kumar Emany Chief Financial Officer | BEAM Beam Therapeutics Inc. | Sale | 6,294 | $27.10 | $170.6K Sale | Form 4 ↗ |
| Dec 31, 2025 | Christine Bellon Chief Legal Officer | BEAM Beam Therapeutics Inc. | Sale | 1,254 | $27.10 | $34.0K Sale | Form 4 ↗ |
| Oct 27, 2025 | FMR LLC 10% owner | BEAM Beam Therapeutics Inc. | Sale | 459 | $26.68 | $12.2K Sale | Form 4 ↗ |
| Oct 2, 2025 | John M. Evans CEO, Director | BEAM Beam Therapeutics Inc. | Sale | 25,000 | $24.63 | $615.8K Sale | Form 4 ↗ |
| Oct 1, 2025 | Bethany J. Cavanagh SVP, Finance and Treasurer | BEAM Beam Therapeutics Inc. | Sale | 467 | $24.53 | $11.5K Sale | Form 4 ↗ |
| Oct 1, 2025 | Christine Bellon Chief Legal Officer | BEAM Beam Therapeutics Inc. | Sale | 373 | $24.53 | $9,150 Sale | Form 4 ↗ |
| Oct 1, 2025 | John M. Evans CEO, Director | BEAM Beam Therapeutics Inc. | Sale | 25,000 | $24.51 | $612.8K Sale | Form 4 ↗ |
| Jul 30, 2025 | FMR LLC 10% owner | BEAM Beam Therapeutics Inc. | Sale | 48,374 | $20.50 | $991.7K Sale | Form 4 ↗ |
| Jul 3, 2025 | Amy Simon Chief Medical Officer | BEAM Beam Therapeutics Inc. | Sale | 876 | $20.12 | $17.6K Sale | Form 4 ↗ |
| Jul 1, 2025 | Amy Simon Chief Medical Officer | BEAM Beam Therapeutics Inc. | Sale | 374 | $16.94 | $6,336 Sale | Form 4 ↗ |
| Apr 2, 2025 | Amy Simon Chief Medical Officer | BEAM Beam Therapeutics Inc. | Sale | 20,997 | $17.73 | $372.3K Sale | Form 4 ↗ |
| Apr 1, 2025 | Christine Bellon Chief Legal Officer | BEAM Beam Therapeutics Inc. | Sale | 5,674 | $18.35 | $104.1K Sale | Form 4 ↗ |
| Apr 1, 2025 | John M. Evans CEO, Director | BEAM Beam Therapeutics Inc. | Sale | 30,663 | $18.35 | $562.7K Sale | Form 4 ↗ |
| Apr 1, 2025 | Giuseppe Ciaramella President | BEAM Beam Therapeutics Inc. | Sale | 7,434 | $18.35 | $136.4K Sale | Form 4 ↗ |
| Apr 1, 2025 | Bethany J. Cavanagh SVP, Finance and Treasurer | BEAM Beam Therapeutics Inc. | Sale | 3,015 | $18.35 | $55.3K Sale | Form 4 ↗ |
| Apr 1, 2025 | Amy Simon Chief Medical Officer | BEAM Beam Therapeutics Inc. | Sale | 9,566 | $18.35 | $175.5K Sale | Form 4 ↗ |
| Feb 18, 2025 | Bethany J. Cavanagh SVP, Finance and Treasurer | BEAM Beam Therapeutics Inc. | Sale | 6,287 | $35.00 | $220.0K Sale | Form 4 ↗ |
| Feb 14, 2025 | Christine Bellon Chief Legal Officer | BEAM Beam Therapeutics Inc. | Sale | 10,000 | $34.00 | $340.0K Sale | Form 4 ↗ |
| Jan 2, 2025 | Christine Bellon Chief Legal Officer | BEAM Beam Therapeutics Inc. | Sale | 1,241 | $24.68 | $30.6K Sale | Form 4 ↗ |
| Jan 2, 2025 | Bethany J. Cavanagh SVP, Finance and Treasurer | BEAM Beam Therapeutics Inc. | Sale | 1,117 | $24.68 | $27.6K Sale | Form 4 ↗ |
| Nov 6, 2024 | Giuseppe Ciaramella President | BEAM Beam Therapeutics Inc. | Sale | 51,110 | $26.36 | $1.3M Sale | Form 4 ↗ |
| Oct 14, 2024 | Giuseppe Ciaramella President | BEAM Beam Therapeutics Inc. | Sale | 51,110 | $26.27 | $1.3M Sale | Form 4 ↗ |
The newest 50 items, most recent first. Every row links to its original filing. Updated Nov 15, 2026, 5:25 PM EST.
Download CSV The rows of this feed, with the filters above. A download holds at most 10,000 rows; narrow the filters to get a smaller slice.
Other feeds: Congressional trades · Executive-branch trades · Bills in Congress · Roll-call votes · Corporate PAC donations · Lobbying · Capitol Hires · Lobbying and contracts · Government contracts · Planned insider sales · Executive pay · Ownership stakes (13D / 13G) · Institutional holdings (13F) · Short interest · Fails to deliver · Daily short volume · Wikipedia page views · App store ratings · H-1B visa applications · Stock splits · 8-K events · IPO filings · Deals · Private placements (Form D) · Merger clearances (HSR) · Layoff notices (WARN) · SEC enforcement · Patents · Clinical trial updates · FDA approvals and clearances